Examinant per Autoria "Hernandez, Maria-Clemencia"
Mostrant 1 - 1 de 1
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome(BioMed Central, 2022) Goeldner, Celia; Kishnani, Priya; Skotko, Brian G.; Lirio Casero, Julian; Hipp, Joerg F.; Derks, Michael; Hernandez, Maria-Clemencia; Khwaja, Omar; Lennon-Chrimes, Sian; Noeldeke, Jana; Pellicer, Sabine; Squassante, Lisa; Visootsak, Jeannie; Wandel, Christoph; Fontoura, Paulo; Liogier d'Ardhuy, Xavier; Clematis Study Group